Speakers:
Julie Shaw. Head, Division of Biochemistry and Director of POCT. The Ottawa Hospital, EORLA and The University of Ottawa.
Dr. Julie Shaw is the chair of the CSCC SIG for POCT and the CSCC representative on the IFCC POCT Working Group. She is the Regional Discipline Lead for Biochemistry and POCT at the Eastern Ontario Regional Laboratories Association.
Dr Vincent De Guire. Clinical Biochemist. Maisonneuve-hospital, Optilab Montréal-Chum network.
Dr Vincent De Guire is the chair of the CSCC SIG on Quality Improvement through QIs monitoring and the president of the Program for QIs comparison of the SQBC. He is notably a member of the WG Laboratory errors and patient safety and corresponding member of the committee Omic Translation of the IFCC. Dr De Guire also act as an expert on the WG on the pre-analytical phase of the EFLM.
Overview:
Quality improvement of processes through Quality Indicators (QI) monitoring is essential for patient safety and required for ISO15189 accreditation. As laboratory medicine professionals, assessment of the robustness of our processes through benchmarking and laboratory comparison must be a priority. To achieve this, standardization of QI monitoring between sites as well as a program for comparison are essentials. In this presentation, guidelines and tools available at the national and international level for QI monitoring will be reviewed. Strategies for benchmarking as well as methodology for QIs selection will be discussed. The work of the joint CSCC SIGs (QI and POCT) for selection of QIs in POCT will be presented.
Objectives:
At the end of this activity, participants will be able to:
- Improve their knowledge on initiatives available in Canada for processes improvement and on international guidelines in the QIs field.
- Be able to describe strategies for benchmarking and QIs selection based on risk assessment.
- Be aware of the Canadian initiative on QIs standardization and comparison in POCT.